# Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer

> **NCT02551471** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 165 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **OTHER:** Blinded inter-country reading of pelvic MRI (Magnetic Resonance Imaging)
- **OTHER:** MDT (Multidisciplinary team) meeting observation
- **OTHER:** Semi-structured exploratory interviews and focus group with MDT health professional attendees

## Key facts

- **NCT ID:** NCT02551471
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2018-05-04
- **Final completion:** 2018-07
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551471, "Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02551471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*